Focus Taiwan App
Download

Human cloning, regenerative therapy need regulation: Nobel laureates

05/08/2018 08:51 AM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, May 8 (CNA) While stem cell research holds potential for understanding and treating diseases, regulation of its application is of equal importance in view of the unscrupulous marketing tactics touting regenerative therapy and the progress being made toward human cloning, Nobel Prize-winning scientists said in Taipei recently.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.
    172.30.142.241